Lv1
10 积分 2022-02-17 加入
Targeting NK cell CLEC12B enhances cancer immunotherapy
15小时前
待确认
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
1个月前
已完结
Engineering innate immune cells for cancer immunotherapy
8个月前
已完结
The landscape of CAR-engineered innate immune cells for cancer immunotherapy
8个月前
已完结